US Stock MarketDetailed Quotes
FOXO FOXO Technologies
- 0.2338
- -0.0169-6.74%
Close Jul 19 16:00 ET
- 0.2339
- +0.0001+0.04%
Post 19:11 ET
2.64MMarket Cap-58P/E (TTM)
0.2501High0.2255Low364.68KVolume0.2500Open0.2507Pre Close86.31KTurnover4.30%Turnover RatioLossP/E (Static)11.28MShares3.280052wk High-0.18P/B1.98MFloat Cap0.220052wk Low--Dividend TTM8.49MShs Float110.0000Historical High--Div YieldTTM9.81%Amplitude0.2200Historical Low0.2360Avg Price1Lot Size
About FOXO Technologies Company
FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment refers to the research and development and is commercializing proprietary epigenetic biomarker technology. The FOXO Life segment is involved in combining life insurance with a dynamic molecular health and wellness platform. The company was founded in 2020 and is headquartered in Minneapolis, MN.
Company Profile
SymbolFOXO
Company NameFOXO Technologies
Listing DateJan 29, 2021
Founded2020
CEOMr. Mark White
MarketAMEX
Employees3
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address729 North Washington Avenue,Suite 600
CityMinneapolis
ProvinceMinnesota
CountryUnited States of America
Zip Code55401
Phone1-612-562-9447
Company Executives
- Name
- Position
- Salary
- Mark White
- Interim Chief Executive Officer and Director
- --
- Bryce Quin, C.P.A.
- Chief Financial Officer, Principal Accounting Officer and Secretary
- --
- Martin Ward
- Interim Chief Financial Officer
- --
- Bret Barnes
- Chairman of the Board
- 744.08K
- Michael T. Gray
- Director
- --
- Dr. Murdoc Khaleghi, M.D.
- Independent Director
- 435.50K
- Paul Britton Newhouse
- Independent Director
- --
- Senator E. Benjamin Nelson
- Independent Director
- --
- Ryan Rugg
- Independent Director
- --
- Francis Colt deWolf, III
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg